1. Topical ophthalmic agents and their effects upon the eye

   Newsletter Article 04 February 2013 Pages: 1 - 2

2. What are the risks of anticoagulants in pregnancy?

   Newsletter Article 04 February 2013 Pages: 2 - 2

3. Centrally acting drugs

   Newsletter Article 04 February 2013 Pages: 2 - 2

4. Antimitochondrial antibodies on labetalol

   Newsletter Article 04 February 2013 Pages: 2 - 2

5. Systemic reactions of regional bupivacaine

   Newsletter Article 04 February 2013 Pages: 2 - 2

6. Acetaminophen

   Newsletter Article 04 February 2013 Pages: 3 - 3

7. Acetaminophen overdose

   Newsletter Article 04 February 2013 Pages: 3 - 3

8. Amphotericin B

   Newsletter Article 04 February 2013 Pages: 3 - 3

9. Aminoglutethimide

   Newsletter Article 04 February 2013 Pages: 3 - 3

10. Azathioprine

    Newsletter Article 04 February 2013 Pages: 4 - 4

11. Cancer chemotherapy

    Newsletter Article 04 February 2013 Pages: 4 - 4

12. Corticotropin

    Newsletter Article 04 February 2013 Pages: 4 - 4

13. Dapsone overdose

    Newsletter Article 04 February 2013 Pages: 4 - 4

14. Diethylstilbestrol

    Newsletter Article 04 February 2013 Pages: 4 - 4

15. Dimethylsulfoxide

    Newsletter Article 04 February 2013 Pages: 4 - 4

16. Enflurane

    Newsletter Article 04 February 2013 Pages: 5 - 5

17. Estrogen

    Newsletter Article 04 February 2013 Pages: 5 - 5

18. Gentamicin

    Newsletter Article 04 February 2013 Pages: 5 - 5

19. Gold sodium thiomalate

    Newsletter Article 04 February 2013 Pages: 5 - 5

20. Insulin

    Newsletter Article 04 February 2013 Pages: 5 - 5

21. Interferon

    Newsletter Article 04 February 2013 Pages: 5 - 5

22. Metrizamide*

    Newsletter Article 04 February 2013 Pages: 5 - 6

23. Morphine*

    Newsletter Article 04 February 2013 Pages: 6 - 6

24. Nifedipine*

    Newsletter Article 04 February 2013 Pages: 6 - 6

25. Oral contraceptives

    Newsletter Article 04 February 2013 Pages: 6 - 6

26. Oral contraceptive interaction

    Newsletter Article 04 February 2013 Pages: 6 - 6

27. Penicillamine

    Newsletter Article 04 February 2013 Pages: 7 - 7

28. Prazosin*

    Newsletter Article 04 February 2013 Pages: 7 - 7

29. Rifampin

    Newsletter Article 04 February 2013 Pages: 7 - 7

30. Rifampin interaction see Oral contraceptives

    Newsletter Article 04 February 2013 Pages: 7 - 7

31. Theophylline*

    Newsletter Article 04 February 2013 Pages: 7 - 7

32. Thiotepa

    Newsletter Article 04 February 2013 Pages: 7 - 7

33. Vincristine*

    Newsletter Article 04 February 2013 Pages: 7 - 7

34. Warfarin

    Newsletter Article 04 February 2013 Pages: 7 - 7

35. Ticarcillin

    Newsletter Article 04 February 2013 Pages: 8 - 9

36. Illicit use of diphenoxylate to prevent narcotic withdrawal symptoms

    Newsletter Article 04 February 2013 Pages: 9 - 9

37. Alcohol-benzodiazepine withdrawal symptoms assessed

    Newsletter Article 04 February 2013 Pages: 9 - 9

38. Hyperkalemia associated with heroin abuse

    Newsletter Article 04 February 2013 Pages: 9 - 9

39. Hyperthyroxinemia observed in amphetamine abusers

    Newsletter Article 04 February 2013 Pages: 9 - 10

40. Enlarged heart and severe respiratory problems follow voluntary chlorine inhalation

    Newsletter Article 04 February 2013 Pages: 10 - 10

41. Lung disease in family members of asbestos workers

    Newsletter Article 04 February 2013 Pages: 10 - 10

42. Atypical ventricular tachycardia after arsenic

    Newsletter Article 04 February 2013 Pages: 10 - 10

43. Acute interstitial nephritis

    Newsletter Article 04 February 2013 Pages: 11 - 11

44. Reactions with penicillamine

    Newsletter Article 04 February 2013 Pages: 11 - 12